【レポートの概要（一部）】
Table of Contents
Chapter 1 Research Methodology
1.1 Information Procurement
1.2 Data Analysis
Chapter 2 Executive Summary
Chapter 3 Predictive Genetic Testing & Consumer/Wellness Genomics Market Variables, Trends & Scope
3.1 Market Segmentation & Scope
3.1.1 Market Driver Analysis
3.1.1.1 Rise in number of novel partnership models
3.1.1.2 Introduction of fragmented point-solutions across the genomics value chain
3.1.1.3 Exponentially decreasing costs for genetic sequencing
3.1.1.4 Introduction of technological advancements in cloud computing and data integration
3.1.2 Market Restraint Analysis
3.1.2.1 Absence of well-defined regulatory framework and low adoption rate
3.1.2.2 Ethical concerns pertaining to implementation
3.2 Penetration & Growth Prospect Mapping for Applications, 2015
3.3 Predictive genetic testing & consumer/wellness genomics-Swot Analysis, By Factor (Political & Legal, Economic And Technological)
3.4 Industry Analysis – Porter’s
Chapter 4 Predictive Genetic Testing & Consumer/Wellness Genomics Market: Test Type Estimates & Trend Analysis
4.1 Predictive Genetic Testing & Consumer/Wellness Genomics Market: Test Types Movement Analysis
4.2 Predictive Testing
4.2.1 Global predictive testing market, 2013 – 2025 (USD Million)
4.2.2 Genetic susceptibility test
4.2.2.1 Global genetic susceptibility test market, 2013 – 2025 (USD Million)
4.2.3 Predictive diagnostics
4.2.3.1 Global predictive diagnostics test market, 2013 – 2025 (USD Million)
4.2.4 Population screening programs
4.2.4.1 Global population screening programs market, 2013 – 2025 (USD Million)
4.3 Consumer Genomics
4.3.1 Global consumer genomics market, 2013 – 2025 (USD Million)
4.4 Wellness Genetics
4.4.1 Global wellness genetics market, 2013 – 2025 (USD Million)
4.4.2 Nutria Genetics
4.4.2.1 Global nutria genetics market, 2013 – 2025 (USD Million)
4.4.3 Skin & Metabolism Genetics
4.4.3.1 Global skin & metabolism genetics market, 2013 – 2025 (USD Million)
4.4.4 Others
4.4.4.1 Global others market, 2013 – 2025 (USD Million)
Chapter 5 Predictive Genetic Testing & Consumer/Wellness Genomics Market: Application Estimates & Trend Analysis
5.1 Predictive Genetic Testing & Consumer/Wellness Genomics Market: Application Movement Analysis
5.2 Breast & Ovarian Cancer Screening
5.2.1 Global breast & ovarian cancer screening market, 2013 – 2025 (USD Million)
5.3 Cardiovascular Screening
5.3.1 Global cardiovascular screening market, 2013 – 2025 (USD Million)
5.4 Diabetic Screening & Monitoring
5.4.1 Global diabetic screening & monitoring market, 2013 – 2025 (USD Million)
5.5 Colon Cancer Screening
5.5.1 Global colon cancer screening market, 2013 – 2025 (USD Million)
5.6 Parkinsonism / Alzheimer’s disease
5.6.1 Global Parkinsonism / Alzheimer’s disease market, 2013 – 2025 (USD Million)
5.7 Urologic Screening/ Prostate Cancer Screening
5.7.1 Global urologic screening/ prostate cancer screening market, 2013 – 2025 (USD Million)
5.8 Orthopedic & Musculoskeletal Screening
5.8.1 Global orthopedic & musculoskeletal screening market, 2013 – 2025 (USD Million)
5.9 Other Cancer Screening
5.9.1 Global other cancer screening market, 2013 – 2025 (USD Million)
5.10 Other Diseases Screening
5.10.2 Global other diseases screening market, 2013 – 2025 (USD Million)
Chapter 6 Predictive Genetic Testing & Consumer/Wellness Genomics Market: Regional Estimates & Trend Analysis, by Test Type & Application
6.1 Predictive Genetic Testing & Consumer/Wellness Genomics Market Share By Region, 2015 & 2025
6.2 North America
6.2.1 Predictive genetic testing & consumer/wellness genomics market, 2013 – 2025 (USD Million)
6.2.2 U.S.
6.2.2.1 Predictive genetic testing & consumer/wellness genomics market, 2013 – 2025 (USD Million)
6.2.3 Canada
6.2.3.1 Predictive genetic testing & consumer/wellness genomics market, 2013 – 2025 (USD Million)
6.3 Europe
6.3.1 Predictive genetic testing & consumer/wellness genomics market, 2013 – 2025 (USD Million)
6.3.2 Germany
6.3.2.1 Predictive genetic testing & consumer/wellness genomics market, 2013 – 2025 (USD Million)
6.3.3 UK
6.3.3.1 Predictive genetic testing & consumer/wellness genomics market, 2013 – 2025 (USD Million)
6.4 Asia Pacific
6.4.1 Predictive genetic testing & consumer/wellness genomics market, 2013 – 2025 (USD Million)
6.4.2 Japan
6.4.2.1 Predictive genetic testing & consumer/wellness genomics market, 2013 – 2025 (USD Million)
6.4.3 China
6.4.3.1 Predictive genetic testing & consumer/wellness genomics market, 2013 – 2025 (USD Million)
6.4.4 Australia
6.4.4.1 Predictive genetic testing & consumer/wellness genomics market, 2013 – 2025 (USD Million)
6.4.5 India
6.4.5.1 Predictive genetic testing & consumer/wellness genomics market, 2013 – 2025 (USD Million)
6.4.6 Singapore
6.4.6.1 Predictive genetic testing & consumer/wellness genomics market, 2013 – 2025 (USD Million)
6.5 Latin America
6.5.1 Predictive genetic testing & consumer/wellness genomics market, 2013 – 2025 (USD Million)
6.5.2 Brazil
6.5.2.1 Predictive genetic testing & consumer/wellness genomics market, 2013 – 2025 (USD Million)
6.6 MEA
6.6.1 Predictive genetic testing & consumer/wellness genomics market, 2013 – 2025 (USD Million)
6.6.2 South Africa
6.6.2.1 Predictive genetic testing & consumer/wellness genomics market, 2013 – 2025 (USD Million)
Chapter 7 Competitive Landscape
7.1 Strategy framework
7.2 Market participation categorization
7.2.1 Key Initiatives
7.3 Company Profiles
7.3.1 F. Hoffmann-La Roche Ltd
7.3.1.1 Company overview
7.3.1.1.1 454 Life Sciences (Roche Diagnostics Corporation)
7.3.1.2 Financial performance
7.3.1.3 Product benchmarking
7.3.1.4 Strategic initiatives
7.3.2 Abbott (Abbott Diagnostics)
7.3.2.1 Company overview
7.3.2.2 Financial performance
7.3.2.3 Product benchmarking
7.3.2.4 Strategic initiatives
7.3.3 Thermo Fisher Scientific, Inc.
7.3.3.1 Company overview
7.3.3.1.1 Affymetrix, Inc.
7.3.3.1.2 Applied Biosystems
7.3.3.2 Financial performance
7.3.3.2.1 Financial performance (Affymetrix)
7.3.3.3 Product benchmarking
7.3.3.4 Strategic initiatives
7.3.4 Agilent Technologies
7.3.4.1 Company overview
7.3.4.2 Financial performance
7.3.4.3 Product benchmarking
7.3.4.4 Strategic initiatives
7.3.5 BGI
7.3.5.1 Company overview
7.3.5.1.1 Complete Genomics Incorporated
7.3.5.2 Financial performance
7.3.5.3 Product benchmarking
7.3.5.4 Strategic initiatives
7.3.6 Bio-Rad Laboratories, Inc.
7.3.6.1 Company overview
7.3.6.1.1 GnuBIO, Inc.
7.3.6.2 Financial performance
7.3.6.3 Product benchmarking
7.3.6.4 Strategic initiatives
7.3.7 Illumina, Inc.
7.3.7.1 Company overview
7.3.7.2 Financial performance
7.3.7.3 Product benchmarking
7.3.7.4 Strategic initiatives
7.3.8 QIAGEN
7.3.8.1 Company overview
7.3.8.2 Financial performance
7.3.8.3 Product benchmarking
7.3.8.4 Strategic initiatives
7.3.9 Alere
7.3.9.1 Company overview
7.3.9.2 Financial performance
7.3.9.3 Product benchmarking
7.3.9.4 Strategic initiatives
7.3.10 Myriad Genetics, Inc.
7.3.10.1 Company overview
7.3.10.2 Financial performance
7.3.10.3 Product benchmarking
7.3.10.4 Strategic initiatives
7.3.11 Siemens Healthineers
7.3.11.1 Company overview
7.3.11.2 Financial performance
7.3.11.3 Product benchmarking
7.3.11.4 Strategic initiatives
7.3.12 Pathway Genomics
7.3.12.1 Company overview
7.3.12.2 Financial performance
7.3.12.3 Product benchmarking
7.3.12.4 Strategic initiatives
7.3.13 Cooper Surgical, Inc.
7.3.13.1 Company overview
7.3.13.1.1 Genesis Genetics
7.3.13.1.2 Reprogenetics
7.3.13.1.3 Financial performance
7.3.13.1.4 Financial performance
7.3.13.2 Product benchmarking
7.3.13.3 Strategic initiatives
7.3.14 Ambry Genetics Corporation
7.3.14.1 Company overview
7.3.14.2 Financial performance
7.3.14.3 Product benchmarking
7.3.14.4 Strategic initiatives
7.3.15 23andMe, Inc.
7.3.15.1 Company overview
7.3.15.2 Financial performance
7.3.15.3 Product benchmarking
7.3.15.4 Strategic initiatives
7.3.16 Danaher
7.3.16.1 Company overview
7.3.16.1.1 Beckman Coulter, Inc.
7.3.16.2 Financial performance
7.3.16.3 Product benchmarking
7.3.16.4 Strategic initiatives
7.3.17 Cepheid
7.3.17.1 Company overview
7.3.17.2 Financial performance
7.3.17.3 Product benchmarking
7.3.17.4 Strategic initiatives
7.3.18 Hologic, Inc. (Gen-Probe Incorporated)
7.3.18.1 Company overview
7.3.18.2 Financial performance
7.3.18.3 Product benchmarking
7.3.18.4 Strategic initiatives
7.3.19 ARUP Laboratories
7.3.19.1 Company overview
7.3.19.2 Financial performance
7.3.19.3 Product benchmarking
7.3.19.4 Strategic initiatives
7.3.20 GUARDANT HEALTH, INC
7.3.20.1 Company overview
7.3.20.2 Financial performance
7.3.20.3 Product benchmarking
7.3.20.4 Strategic initiatives
7.3.21 Advanced Genomic Solutions (AGS) Ltd
7.3.21.1 Company overview
7.3.21.2 Financial performance
7.3.21.3 Product benchmarking
7.3.21.4 Strategic initiatives
7.3.22 EasyDNA
7.3.22.1 Company overview
7.3.22.2 Financial performance
7.3.22.3 Product benchmarking
7.3.22.4 Strategic initiatives
7.3.23 Color Genomics, Inc.
7.3.23.1 Company overview
7.3.23.2 Financial performance
7.3.23.3 Product benchmarking
7.3.23.4 Strategic initiatives
7.3.24 Counsyl, Inc.
7.3.24.1 Company overview
7.3.24.2 Financial performance
7.3.24.3 Product benchmarking
7.3.24.4 Strategic initiatives
7.3.25 Gene by Gene
7.3.25.1 Company overview
7.3.25.2 Financial performance
7.3.25.3 Product benchmarking
7.3.26 Mapmygenome
7.3.26.1 Company overview
7.3.26.2 Financial performance
7.3.26.3 Product benchmarking
7.3.26.4 Strategic initiatives
7.3.27 Interleukin Genetics Inc.
7.3.27.1 Company overview
7.3.27.2 Financial performance
7.3.27.3 Product benchmarking
7.3.27.4 Strategic initiatives
7.3.28 Laboratory Corporation of America Holdings (LabCorp)
7.3.28.1 Company overview
7.3.28.2 Financial performance
7.3.28.3 Product benchmarking
7.3.28.4 Strategic initiatives
7.3.29 Quest Diagnostics Incorporated
7.3.29.1 Company overview
7.3.29.1.1 Sonora Quest Laboratories
7.3.29.2 Financial performance
7.3.29.2.1 Financial performance
7.3.29.3 Product benchmarking
7.3.29.4 Strategic initiatives
7.3.30 Xcode
7.3.30.1 Company overview
7.3.30.2 Financial performance
7.3.30.3 Product benchmarking
7.3.30.4 Strategic initiatives
7.3.31 Amgen, Inc.
7.3.31.1 Company overview
7.3.31.1.1 deCODE genetics
7.3.31.2 Financial performance (Amgen, Inc.)
7.3.31.3 Product benchmarking
【レポート販売概要】
■ タイトル：予測遺伝子検査と消費者/ウェルネスゲノミクスの世界市場分析：用途別（がん、糖尿病のスクリーニング、パーキンソン病、循環器、整形外科･筋骨格系、ヌートリア遺伝学、皮膚･代謝遺伝学）、動向分析、2013-2025■ 英文：Predictive Genetic Testing And Consumer/Wellness Genomics Market By Application (Cancer, Diabetic Screening, Parkinsonism, Cardiovascular, Orthopedic & Musculoskeletal, Nutria Genetics, Skin & Metabolism Genetics), And Trend Analysis From 2013 To 2025
■ 発行日：2017年1月27日
■ 調査会社：Grand View Research
■ 商品コード：GVIEW707698
■ 調査対象地域：グローバル
- グリーン及びバイオ溶剤の世界市場：バイオアルコール、バイオグリコール、バイオジオール、乳酸エステル、D-リモネン、メチルソイアートThe green & bio-solvents market size, in terms of value, is estimated to reach USD 8.17 Billion by 2020, signifying a firm CAGR of over 7.94% between 2015 and 2020. The drivers identified for the green & bio-solvents market are environmental & regulatory pressure designed to reduce the emissions of ODS, VOCs, and HAPs; reduced dependency on petrochemical solvents and the exporting countries; impro …
- ビジネスインテリジェンス（BI）の世界市場2016-2020About Business Intelligence BI is a combination of tools and techniques used to transform raw data into meaningful information for the critical business decision-making process. It helps users to analyze data, receive information from various channels or business activities, and use the information in organizational opportunities and to improve business efficiency. The BI solution, when integrated …
- Osaka Gas Co., Ltd.：石油・ガスバリューチェーン分析レポート2013Osaka Gas Co., Ltd. Analysis Across the Oil and Gas Value Chain Report, 2013 Update Summary "Osaka Gas Co., Ltd." Analysis Across the Oil and Gas Value Chain is an essential source for data, analysis and strategic insight into “Osaka Gas Co., Ltd.”. The report provides key information relating to oil and gas assets of the company along with its operations across the value chain. The report examine …
- Tildrakizumab (Psoriasis)：市場予測と分析（～2022）Tildrakizumab (Psoriasis) - Forecast and Market Analysis to 2022 Summary Psoriasis is an incurable genetic, systemic, inflammatory, and chronic skin disorder with an overall prevalence of 2–3% worldwide (Perera et al., 2012). Specifically, adult plaque psoriasis is the focus of this report and is defined using the 2013 International Classification of Diseases, Tenth Revision, Clinical Modification …
- グローバルにおける政府部門向けGIS（地理情報システム）市場（2014-2018）About Geographic Information Systems A GIS is a set of tools used to interpret geographical or geospatial data or information. This system digitizes the received geospatial data and processes (stores, interprets, analyzes, and manipulates) them to provide the required output. TechNavio's analysts forecast the Global GIS market in the Government sector will grow at a CAGR of 10.00 percent over the …
- 4Kディスプレイ解像度の世界市場（2014 – 2020）4K represents a way by which the resolution can be measured. 4K resolution provides more pixel density which makes the image clearer, crisper, and better. This resolution provides the horizontal resolution close to 4,000 pixels and vertical resolution close to 2000 pixels. There are many standards of 4K resolution which are used for television system broadcasting and for cinemas. This resolution p …
- ライフルスコープの世界市場予測（～2022年）“Increasing popularity of hunting games, shooting sports, and need for precision shooting are expected to drive the riflescope market during the forecast period”The riflescope market is estimated to grow from USD 5.36 billion in 2016 to USD 6.87 billion in 2022, at a CAGR of 4.24% during the forecast period. Increase in the popularity of hunting activities and shooting games is expected to drive t …
- 心臓弁の世界市場：機械式心臓弁、組織心臓弁、経カテーテル心臓弁About the Heart Valves Market Heart valves are prosthetic cardiovascular medical devices used to replace a defective heart valve. They can be biological, tissue or mechanical. Manufacturers develop mechanical heart valves from synthetic materials such as pyrolytic carbon, titanium alloy, and cobalt-based alloys and tissue heart valves from bovine, porcine, and human tissues. They also develop tran …
- 世界の大動脈ステント移植片市場2015The Global Aortic Stent Grafts Industry 2015 Market Research Report is a professional and in-depth study on the current state of the Aortic Stent Grafts industry. The report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure.The Aortic Stent Grafts market analysis is provided for the international markets including developmen …
- 脂肪族炭化水素溶剤・希釈剤の世界市場予測（～2024年）“The aliphatic hydrocarbon solvents & thinners market is projected to grow at a CAGR of 2.7% from 2019 to 2024, in terms of value.” The aliphatic hydrocarbon solvents & thinners market is projected to grow from USD 4.6 billion in 2019 to USD 5.2 billion by 2024, at a CAGR of 2.7% from 2019 to 2024. The increasing demand for aliphatic hydrocarbon solvents & thinners in applications, such as paints …
- 分光分析装置の世界市場：エネルギー分散型X線分光器（EDS）、波長分散型X線分光器（WDS）、電子線後方散乱回折(EBSD) 分析装置、マイクロ蛍光X線分析（マイクロXRF）装置The EDS, WDS, EBSD, and micro-XRF instruments market has registered constant growth over the years. Factors such as the growing semiconductors industry, increasing demand for nanotechnology, demand for automobiles, and technological advancements are propelling the growth of this market. The semiconductors industry is experiencing a robust growth globally. This industry witnessed a growth of 11.5% …
- バイオ系プラットフォーム化学品の世界市場2017-2021：バイオ系1,4-二酸、バイオ系グリセリン、バイオ系グルタミン酸、バイオ系3-ヒドロキシプロピオン酸、バイオ系イタコン酸About Bio-Based Platform Chemicals Bio-based platform chemicals are compounds containing two to six carbons and are derived from renewable resources. They are used as important precursors for producing a variety of chemicals and materials, such as pharmaceuticals, perfumes, solvents, fuels, and polymers. Platform chemicals are two to six carbon-containing compounds derived from fossil fuel resourc …
- PMIフォーム及びその他の高性能フォームコア（HPFC）の世界市場：PMI（ポリメタクリルイミド）フォーム、PES（ポリエーテルスルホン）フォームThe global PMI Foam market and other High Performance Foam Core (HPFC) market is estimated to grow from USD 43.1 Million in 2015 to USD 77.1 Million by 2021, at a CAGR of 10.2% between 2016 and 2021. The global PMI foam market and other HPFC market has witnessed a strong growth in the past few years owing to its high demand from the aerospace & defense application segment. HPFC offers properties s …
- 航空機用・船用ギャレー（厨房設備）の世界市場：用途別、ギャレー種類別、ギャレーインサート種類別、地域別分析The global galley equipment has the potential to grow at a CAGR of 4.10% from 2014 to 2020. This report provides qualitative and quantitative information about the galley equipment market. It identifies the market application gaps, emerging technologies, the need for new product launches, and high potential geographic regions and countries. It also provides a granular segmentation of this market, …
- 世界の食品生産市場におけるバイオテクノロジー動向（2014-2024）The biotechnology in food production market will reach US$101.96bn in 2014. Meeting rising global food needs will demand another era of widespread adoption of innovative, science-based biotechnologies in food production that consider environmental and ecological issues, nutrient deficiencies and other more complex issues. The food system already looks different than it was 20 or 30 years ago: peop …
